Zai Lab (ZLAB) Total Current Liabilities (2016 - 2026)
Zai Lab (ZLAB) reported Total Current Liabilities of $393.0 million for Q1 2026, up 22.88% on a YoY basis from $319.8 million in Q1 2025, and down 5.57% sequentially from $416.2 million in Q4 2025.
Zai Lab (ZLAB) Total Current Liabilities (2016 - 2026) Analysis & Trends
Zai Lab (ZLAB) has 11 years of Total Current Liabilities data on file, last reported at $393.0 million in Q1 2026.
- For the quarter ending Q1 2026, Total Current Liabilities rose 22.88% year-over-year to $393.0 million; the trailing twelve-month figure through Mar 2026 stood at $393.0 million (up 22.88% YoY), and the FY2025 full-year result was $416.2 million, up 39.01% from the prior year.
- Total Current Liabilities eased to $393.0 million in Q1 2026, from $416.2 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $416.2 million in Q4 2025 to a low of $124.6 million in Q1 2023.
- A 5-year average of $238.5 million and a median of $203.1 million in 2023 frame the typical range for Total Current Liabilities.
- Across the five-year window, Total Current Liabilities slipped 27.51% in 2022 and surged 129.24% in 2024, its largest moves.
- Tracing ZLAB's Total Current Liabilities over 5 years: stood at $139.8 million in 2022, then surged by 45.21% to $203.1 million in 2023, then jumped by 47.43% to $299.4 million in 2024, then soared by 39.01% to $416.2 million in 2025, then declined by 5.57% to $393.0 million in 2026.
- Business Quant data shows ZLAB's Total Current Liabilities at $393.0 million in Q1 2026, $416.2 million in Q4 2025, and $359.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 56.01 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 66.94 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 13.42 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.81 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 3.88 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 5.11 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 289.60 Mn |
| 10 | Zai Lab | 21.37 Bn | 21.37 Bn | -34.26 Mn | 392.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 392.98 Mn |
| Dec 31, 2025 | 416.17 Mn |
| Sep 30, 2025 | 359.77 Mn |
| Jun 30, 2025 | 331.50 Mn |
| Mar 31, 2025 | 319.81 Mn |
| Dec 31, 2024 | 299.39 Mn |
| Sep 30, 2024 | 286.32 Mn |
| Jun 30, 2024 | 251.72 Mn |
| Mar 31, 2024 | 192.11 Mn |
| Dec 31, 2023 | 203.07 Mn |
| Sep 30, 2023 | 124.90 Mn |
| Jun 30, 2023 | 133.35 Mn |
| Mar 31, 2023 | 124.56 Mn |
| Dec 31, 2022 | 139.84 Mn |
| Sep 30, 2022 | 155.55 Mn |
| Jun 30, 2022 | 168.88 Mn |
| Mar 31, 2022 | 154.91 Mn |
| Dec 31, 2021 | 192.90 Mn |
| Sep 30, 2021 | 112.01 Mn |
| Jun 30, 2021 | 193.92 Mn |